AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02971371 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lokomat
Description: Both the groups performed 40 45min Lokomat sessions, five times a week, between 9am and 11am. The RAGTand VR group received a visual feedback showing a VR run game where the patient had to collect or avoid objects, to motivate him/her to walk actively. Each avatar's leg movement corresponded to that performed by the patient. On the other hand, the RAGT without VR group was not provided an avatar, and a smile indicating the goodness of each leg movement. The biofeedback of the Lokomat gait orthosis is based on the interaction torques between the participant and the orthosis
Study NCT01627184 — intervention group
Intervention type: DEVICE
Intervention: Dexcom G4 CGM System
Study NCT03899415 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TCR redirected T cells
Description: HBV antigen specific TCR redirected T cell Infusions. Subjects will receive 1x10\^4 - 5x10\^6 TCR redirected T cells by IV infusion.
Study NCT01987388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Exercise
Description: While in the calorimeter, each subject will complete four bouts of exercise. Each bout is approximately 5 minutes in duration at a predetermined speed and elevation to achieve an intensity of 85% of VO2 max according to their fitness level test described previously. Subjects then sit quietly until either the next meal or the next exercise bout.
Study NCT01987388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Intensity Exercise
Description: While in the calorimeter, each subject completes one exercise bout approximately 40 minutes in duration, at a predetermined speed and elevation, to achieve an intensity of 65% of VO2 max. Subjects then sit quietly until the next meal.
Study NCT01987388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Carbohydrate Beverage
Description: Participants will consume a high carbohydrate beverage (750 g) with the following composition: 2.13 MJ/d, 113g carbohydrate, 4g fat, 6g protein.
Study NCT01987388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Fat Beverage
Description: Participants will consume a high fat beverage (750 g) with the following composition: 2.11 MJ/d, 8g carbohydrate, 50g fat, 7g protein.
Study NCT03435263 — intervention group
Intervention type: OTHER
Intervention: home management
Description: pregnant women presented with PROM will be randomized into 2 groups group a will be discharged home after initial assessment and group B will be admitted to hospital as usual
Study NCT03493139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Across the Curriculum
Description: Activity breaks will be designed for delivery in the classroom without reconfiguration of the classroom space. Activities will emphasize whole body movements, using large muscle groups. Each break includes multiple activities. Each activity lasts about 2 minutes. There will be a total of about 20 minutes of physical activity done each school day.
Study NCT03801941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: wearing ATLAS device during evaluation at 5th day
Description: Wearing the ATLAS device 60 min per day during 5 days and evaluation of pain during standardized activities without ATLAS Device at the 4th or 5th day of a 4 weeks rehabilitation program.
Study NCT01543555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Atorvastatin 80mg anytime within 18 hours before surgery. A postoperative 40mg atorvastatin dose administered at least 12 hours after the 80mg loading dose. Subsequently, 40mg atorvastatin daily for the next seven days.
Study NCT04587453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tralokinumab
Description: Tralokinumab is a human recombinant monoclonal antibody of the immunoglobulin G4 subclass that specifically binds to human interleukin-13 (IL-13) and blocks the interaction with IL-13 receptors. It is presented as a liquid formulation for subcutaneous administration.
Study NCT04587453 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo contains the same excipients in the same concentration only lacking tralokinumab.
Study NCT04587453 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Topical corticosteroids (TCS)
Description: TCS administered as needed.
Study NCT04587453 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (TCS)
Description: TCS administered as needed.
Study NCT03337139 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Gold Standard Behavior Therapy for Weight Loss
Description: Group-based behavioral treatment for weight loss, with a standard emphasis on diet (65% of session) and physical activity goals (25% of session). Other weight loss behaviors such as self monitoring will be covered in the remaining time (10% of session). Participants will be asked to utilize digital monitoring devices for physical activity, weight, and diet. Coaches will not have access to the digital data that participants provide on physical activity, weight, and diet monitoring devices.
Study NCT03337139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gold Standard Behavior Therapy for Weight Loss
Description: Group-based behavioral treatment for weight loss, with a standard emphasis on diet (65% of session) and physical activity goals (25% of session). Other weight loss behaviors such as self monitoring will be covered in the remaining time (10% of session). Participants will be asked to utilize digital monitoring devices for physical activity, weight, and diet. Coaches will not have access to the digital data that participants provide on physical activity, weight, and diet monitoring devices.
Study NCT03337139 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Remote Behavior Therapy for Weight Loss
Description: Individual, monthly, brief phone calls with coach and weekly text messages. The content of these calls and messages will be determined by participant self-report. Coaches will not have access to the digital data that participants provide on physical activity, weight, and diet monitoring devices.
Study NCT03337139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Data Sharing Behavior Therapy for Weight Loss
Description: Individual, monthly, brief phone calls with coach and weekly text messages. The content of these calls and messages will be determined by the digital data that has been shared with the coach from physical activity, weight, and diet monitoring devices.
Study NCT02245451 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tipranavir
Study NCT02245451 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Study NCT02245451 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methadone
Study NCT01543555 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo 80mg anytime within 18 hours before surgery. A postoperative 40mg matching placebo dose administered at least 12 hours after the 80mg loading dose. Subsequently, 40mg placebo daily for the next seven days.
Study NCT02172092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SodiumChloride
Description: Infusion of SodiumChloride, blood samples to calculate extracellular volume.
Study NCT01536002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Intravenous infusion over 30 min of Propofol 3-4 mg/kg body weight
Study NCT01814683 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Primaquine
Description: 14 days of supervised primaquine (7mg/kg total dose) administered once per day (0.5 mg/kg).
Study NCT01814683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Primaquine
Description: 7 days of supervised primaquine (7mg/kg total dose) administered once per day (1.0 mg/kg OD) followed by 7 days of placebo.
Study NCT01814683 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 14 days placebo.
Study NCT00111475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romiplostim
Description: Administered by subcutaneous injection
Study NCT04128202 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sunnyside
Description: The Sunnyside intervention is an online intervention (an interactive website with didactic material and interactive tools) targeting skills to manage mood during and after pregnancy. The Sunnyside intervention will consist of 6weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum. Each lesson takes approximately 10 minutes to complete.
Study NCT04128202 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sunnyside Plus
Description: Sunnyside Plus will build upon the Sunnyside intervention, plus include additional education and support to promote breastfeeding. Breastfeeding education and skills will be provided during the 6weeks of online lessons during pregnancy; each lesson takes approximately 10 minutes to complete. Breastfeeding support will continue through 6 weeks postpartum. This postpartum support will involve weekly online lessons(each taking approximately 10 minutes to complete), text support messages(3 sent during weeks 1 and 2, 2 sent during weeks 3 and 4, 1 sent during weeks 5 and 6), and video support calls with a Lactation Educator (LE)provided on an as-needed basis(exception: at least 1 video call is required during both week 1 postpartum and week 2 postpartum).
Study NCT02382926 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Capacitive ECG and contactless heart and breathing rate measurements via camera
Description: During a 30 minute driving simulation cardiologic patients in rehabilitation undergo capacitive ECG measurements via sensors in the car seat as well as heart and breathing rate measurements via camera according to the Eulerian Magnification Method.
Study NCT01690975 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo - single dose at start of each treatment period
Study NCT00111475 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered by subcutaneous injection
Study NCT03051087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ganirelix acetate
Study NCT03051087 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ganirelix acetate
Study NCT01784952 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: The intervention program consisted of replacing of refined rice intake with 1/3 of legumes, 1/3 of barleys, and 1/3 of whole grains three times per day as a high carbohydrate source and increased vegetable intake to at least 6 units (30-70 g/unit) per day for sufficient dietary fiber intake. The subjects were recommended to drink no more than one alcoholic beverage drink (15 g alcohol) per day and were assigned physical activity consisting of a regular 30-min walk after dinner each day. Participants were also instructed to record their physical activity diary for 24 h every 4 weeks.
Study NCT01784952 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Dietary intervention
Description: The intervention program consisted of replacing of refined rice intake with 1/3 of legumes, 1/3 of barleys, and 1/3 of whole grains three times per day as a high carbohydrate source and increased vegetable intake to at least 6 units (30-70 g/unit) per day for sufficient dietary fiber intake. The subjects were recommended to drink no more than one alcoholic beverage drink (15 g alcohol) per day and were assigned physical activity consisting of a regular 30-min walk after dinner each day. Participants were also instructed to record their physical activity diary for 24 h every 4 weeks.
Study NCT02731807 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dose A: TA-65 24mg, powder
Study NCT01690975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benzonatate - 400 mg
Description: Benzonatate - 400 mg single dose
Study NCT01690975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benzonatate - 600 mg
Description: Benzonatate - 600 mg single dose
Study NCT01111214 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: There is no intervention. This is a non interventional study.
Study NCT01091272 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-04995274
Description: Planned single PO 0.15mg, 1.5mg, 15mg doses of PF-04995274 interleaved with cohort 2 such that doses escalate from 0.15 mg to 50 mg.
Study NCT01091272 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-04995274
Description: Planned single PO 0.5mg, 5mg, 50mg doses of PF-04995274, interleaved with cohort 2 such that doses escalate from 0.15 mg to 50 mg interleaved with cohort 2 such that doses escalate from 0.15 mg to 50 mg.
Study NCT02433405 — intervention group
Intervention type: BIOLOGICAL
Intervention: Serum Amyloid A
Description: Acute phase protein
Study NCT02731807 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dose B: TA-65, 8mg, powder
Study NCT02731807 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dose C: TA-65 3.2mg, capsule
Study NCT02441881 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency Induced Thermal Therapy
Description: Endovenous radiofrequency device
Study NCT01355757 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Baxter INFUSOR System
Description: Regional Analgesia INFUSOR system with Patient Control Module for post-operative analgesia
Study NCT02441881 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endovenous Radiofrequency
Description: Endovenous radiofrequency device
Study NCT02731807 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dose D: TA-65 8mg, capsule
Study NCT02731807 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dose E: TA-65 32mg, capsule
Study NCT01413841 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nasal oxygen
Description: 3 l oxygen
Study NCT01413841 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Regular nasal air
Description: 3 l nasal air
Study NCT02289404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVP-1203
Description: Oral
Study NCT00384826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib
Description: Erlotinib 150 mg/day (until progression)
Study NCT00384826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel + carboplatine
Description: Paclitaxel 90 mg/m² D1, D8, D15 (D1=D28, until progression) Carboplatine AUC 6 D1 (D1=D28, 6 cycles)
Study NCT03431701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Description: Vaginal cleansing will be performed in conjunction with the abdominal preparation with foam sponge that contains chlorhexidine. A sponge soaked with chlorhexidine will be inserted into the vagina and rotated 360 degrees in the vaginal cavity for about 30 seconds
Study NCT03431701 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Iodine
Description: Vaginal cleansing will be performed in conjunction with the abdominal preparation with foam sponge that contains iodine. A sponge soaked with iodine will be inserted into the vagina and rotated 360 degrees in the vaginal cavity for about 30 seconds
Study NCT03431701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antibiotics
Description: All participants will receive a single body mass index (BMI) based antibiotic dose of cefazolin or clindamycin within 30 minutes prior to the incision.
Study NCT03431701 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotics
Description: All participants will receive a single body mass index (BMI) based antibiotic dose of cefazolin or clindamycin within 30 minutes prior to the incision.
Study NCT00675103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pegloticase 8 mg i.v.
Description: pegloticase 8 mg i.v. every 2 weeks for 24 weeks
Study NCT02462733 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tools of the Mind (TOM)
Description: TOM is play-based but features explicit, scripted, teacher-directed activities aimed specifically at helping to improve children's self-control skills. Early evidence supports the program efficacy and suggests benefits for children's development more generally (including language, reading and mathematics).
Study NCT02462733 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Playing to Learn (PTL)
Description: PTl is a play based preschool program now in wide use in YMCA childcare settings across Canada (and some in the United States). The activities in PTL are child initiated and are not prescribed. Teachers are trained to observe children at play and to capitalize on learning opportunities as they arise.
Study NCT01790711 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FMT through mid-gut
Study NCT00190983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed: 900 mg/m2 (700 mg/m2 for patients with prior radiotherapy) intravenous (IV) over 10 minutes every 21 days until disease progression.
Study NCT04408066 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sample Collection/Performance Evaluation (A)
Description: This is a prospective sample collection and performance evaluation study which involves no therapeutic intervention.~Sample types include:~* Nasal/Throat/Nasal Throat Combo/ Nasopharyngeal (as per sites SOC) Swab~* Whole Venous Blood
Study NCT04408066 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sample Collection/Performance Evaluation (B)
Description: This is a prospective sample collection and performance evaluation study which involves no therapeutic intervention.~Sample types include:~* Whole Venous Blood~* Fingerstick Capillary Sample
Study NCT01573013 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: iron fortified biscuits
Description: 10 mg of iron per day for 8 months, either in the form of NaFeEDTA
Study NCT01573013 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: iron fortified biscuits
Description: 10 mg of iron per day for 8 months, in the form of FeSo4
Study NCT01573013 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: iron fortified biscuits
Description: EDTA fortified biscuit on a daily basis for 8 months
Study NCT01573013 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: iron fortified biscuits
Description: control biscuit on a daily basis for 8 months
Study NCT03828149 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Drug:OP0201
Description: Drug: OP0201
Study NCT03828149 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Drug: Placebo
Description: Drug: Placebo
Study NCT01213095 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rituximab
Description: rituximab 375mg/m2, every 8 weeks, 12 times
Study NCT04089813 — intervention group
Intervention type: DRUG
Intervention: Metformin
Description: Patients use metformin to control blood sugar
Study NCT02652507 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dexmedetomidine
Description: 2 mc/kg/h over ten minutes followed by a continuous infusion of 2 mcg/kg/h
Study NCT03399916 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prompt sent
Study NCT01388881 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Education
Description: The intervention - music classes - will be methodologically and educationally based on the National Curriculum Parameters that were developed in Brazilian in the 80s; the focus here is centered on a modern approach to music education where the traditional process of musical learning is not restricted to the domain of the musical reading (sheet music), but also includes musical improvisation, composition and interpretation. Children will be encouraged to create their own music; perception and identification of the elements of musical language in production activities will be explained to them by means of voice, body, sound materials and tools available. Song lyrics, rhymes and rap will be created using elements of musical language not focused purely on the classical elements/music.
Study NCT01387906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: topical bimatoprost
Description: topical bimatoprost will be applied one drop to each eyebrow each night.
Study NCT01404182 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vaccination with Fluval AB influenza vaccine
Description: Vaccination with a single dose of Fluval AB influenza vaccine (trivalent, seasonal, active ingredient content: 15 μg HA/0.5mL of seasonal H1N1, H3N2 and B influenza antigens each) and aluminium phosphate gel adjuvant.
Study NCT02274142 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Restoration with hand-mixed material
Description: restoration with hand-mixed glass ionomer cement
Study NCT02652507 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ketamine
Description: Bolus dose 2 mg/kg after first set of research images are obtained
Study NCT01415856 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Device (Torino II)
Description: Device is giving treatment for 15 minutes every 2 hours for a total of two weeks.
Study NCT01415856 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham Device (Torino II)
Description: Device is designed to appear to be giving treatment when it is not actually giving treatment. Patients will wear this for a duration of two weeks.
Study NCT05605483 — intervention group
Intervention type: OTHER
Intervention: Salad bar
Description: Schools where the school district has installed salad bars